Albireo to Present at Investor Conferences in September
Sep 19, 2017 12:24 pm UTC| Business
BOSTON, Sept. 19, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President and Chief Executive...
EVS Receives Order From Taiwan for Multiple Systems
Sep 19, 2017 12:11 pm UTC| Business
CAESAREA, Israel, Sept. 19, 2017 -- Elbit Vision Systems Ltd. (OTC:EVSNF), a pioneer in the science of camera-based automatic vision inspection for textile fabrics and technical webs, announced today that it has...
Avid Bioservices to Exhibit at 2017 BioProcess International Conference & Exhibition
Sep 19, 2017 12:05 pm UTC| Business
TUSTIN, Calif., Sept. 19, 2017 -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the company will exhibit at the upcoming 2017...
Unlimited SharePoint migration, a real game changer for IT pros! Jump to Office 365!
Sep 19, 2017 12:05 pm UTC| Business
Cloudiway is known for its SaaS migration platform - apps.cloudiway.com - a smart tool, powerful and user-friendly to fully automate migration processes and easily move data, contents and users to the cloud. The growing...
Nebia Shower System Receives Prestigious Silver CLIO Award for Product Design
Sep 19, 2017 12:04 pm UTC| Business
SAN FRANCISCO, Sept. 19, 2017 -- Nebia, the innovative shower system that is redefining the shower experience, is proud to announce that it received a Silver CLIO Award, one of the world’s most respected industry...
Sep 19, 2017 12:03 pm UTC| Business
CHANDLER, Ariz., Sept. 19, 2017 -- The PAC1934, a precision power and energy monitoring chip, is now available from Microchip Technology Inc. (NASDAQ:MCHP). The chip works in conjunction with a Microchip software driver...
Aptose to Present at the 17th Annual Biotech in Europe Forum
Sep 19, 2017 12:02 pm UTC| Business
SAN DIEGO, and TORONTO, Sept. 19, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today...